Ocuscreen

How it works
Who is it for
Team
Contacts

AI-powered Diabetic Retinopathy Diagnosis in Seconds

Ocuscreen

Ocuscreen is an AI-powered solution for fast and easy diagnosis of Diabetic Retinopathy. It assists ophthalmologists in the screening of diabetic patients for DR, allowing them to detect the disease at very early stages and prevent blindness for thousands of patients at risk.

Ocuscreen

Diabetic Retinopathy Detection Platform:

Cloud / on-premise options

Fully
automated

High tolerance
to image quality

Result
in 3 seconds

The risk of developing DR ranges from 30 to 54.6% depending on the stage of diabetes

Diabetic Retinopathy Worldwide

There are 400+ mln patients with diabetes worldwide

Diabetic Retinopathy is the second cause of disability among diabetic patients after glaucoma

Most countries face the challenge of regular screening of diabetic patients for DR as a sight-threatening condition

Key Metrics

* on APTOS dataset
Imageability — percent of images which ocuscreen recognises as gradable (done with sufficient quality)

Specificity

(True Negative Rate) refers to the proportion of those who received a negative result on this test out of those who do not actually have the condition (when judged by the ‘Gold Standard’)

Sensitivity

(True Positive Rate) — refers to the proportion of those who received a positive result on this test out of those who actually have the condition (when judged by the ‘Gold Standard’)